Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > LATEST
LATEST
-
BUSINESS 3D “Deeply Disappointed” by Toho Plan to Seek Defense Trigger Approval
May 1, 2026
-
BUSINESS Jardiance Tops Four Promotion Channels in March: Intage
May 1, 2026
-
BUSINESS Sandoz Poaches Regeneron’s Yohei Ishii as Japan Chief
April 30, 2026
-
BUSINESS Nipro to List Forxiga AG in June Ahead of Pricing Rule Shift
April 30, 2026
-
BUSINESS FDA Accepts Zipalertinib NDA for EGFR Exon 20-Mutant Lung Cancer: Taiho
April 30, 2026
-
BUSINESS Otsuka’s IgA Drug Voyxact Sees Strong US Uptake: EVP
April 30, 2026
-
BUSINESS KM Biologics, India’s Serum Institute Partner on Japanese Encephalitis Vaccine
April 30, 2026
-
REGULATORY METI Clarifies Naphtha Comments, Reaffirms Medical Priority
April 30, 2026
-
REGULATORY Japan Minister Rules Out Full Self-Pay for OTC-Like Drugs
April 30, 2026
-
REGULATORY Govt’s Bio-WG Wraps Up Biopharma Investment Roadmap Draft
April 30, 2026
-
REGULATORY Health Insurance Reform Bill Sails Through Lower House
April 30, 2026
-
BUSINESS Japan Drug Sales Top 11 Trillion Yen in FY2025, Keytruda Leads: Encise
April 30, 2026
-
BUSINESS Taiho Moves Araris’ ADC into PI for Lymphoma in US
April 30, 2026
-
BUSINESS Gilead Files Bictegravir Plus Lenacapavir HIV Pill in Japan
April 30, 2026
-
REGULATORY MOF Pushes for Full-Scale FY2027 Off-Year Drug Price Revision Ahead of “Spring” Proposal
April 28, 2026
-
REGULATORY Japan Panel Backs Boehringer’s IPF Drug, Moderna COVID Vaccine
April 28, 2026
-
BUSINESS Astellas Tops 2 Trillion Yen in Sales, Gears Up for Post-Xtandi Growth
April 28, 2026
-
BUSINESS Astellas Taps Sanofi Japan Chief Iwaya as Strategy Officer
April 28, 2026
-
COMMENTARY Shift Underway in Pharma Workforce as Sales Roles Shrink, Manufacturing Rises
April 28, 2026
-
BUSINESS Teikoku, Curedisc Ink Japan Deal for Disc Herniation Drug
April 28, 2026
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…